Connectivity Standards Alliance on LinkedIn: mediola wins Smart Home Germany Award 2023 with Matter - mediola -…
![Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study - The Lancet Oncology Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study - The Lancet Oncology](https://www.thelancet.com/cms/asset/cf667ecf-c4d7-4ea6-83d7-a2b96ead2692/gr2.jpg)
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study - The Lancet Oncology
![Mediola releases Matter multi-protocol bridge and more in our weekly roundup - Matter & Apple HomeKit Blog Mediola releases Matter multi-protocol bridge and more in our weekly roundup - Matter & Apple HomeKit Blog](https://smartapfel.com/wp-content/uploads/2023/07/mediola.jpg)